FR6693M - - Google Patents

Info

Publication number
FR6693M
FR6693M FR109984A FR109984A FR6693M FR 6693 M FR6693 M FR 6693M FR 109984 A FR109984 A FR 109984A FR 109984 A FR109984 A FR 109984A FR 6693 M FR6693 M FR 6693M
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR109984A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Application granted granted Critical
Publication of FR6693M publication Critical patent/FR6693M/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/18—Oxygen atoms
    • C07D263/20—Oxygen atoms attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/18—Oxygen atoms
    • C07D263/20—Oxygen atoms attached in position 2
    • C07D263/24—Oxygen atoms attached in position 2 with hydrocarbon radicals, substituted by oxygen atoms, attached to other ring carbon atoms
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR109984A 1966-06-13 1967-06-12 Expired FR6693M (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US55687266A 1966-06-13 1966-06-13
US75537068A 1968-08-26 1968-08-26

Publications (1)

Publication Number Publication Date
FR6693M true FR6693M (fr) 1969-02-10

Family

ID=27071276

Family Applications (1)

Application Number Title Priority Date Filing Date
FR109984A Expired FR6693M (fr) 1966-06-13 1967-06-12

Country Status (11)

Country Link
US (2) US3455941A (fr)
BE (1) BE699845A (fr)
CH (1) CH555845A (fr)
DE (1) DE1695638A1 (fr)
DK (1) DK127066B (fr)
ES (1) ES341733A1 (fr)
FR (1) FR6693M (fr)
GB (1) GB1167392A (fr)
IL (1) IL28125A (fr)
NL (2) NL6708113A (fr)
SE (1) SE325576B (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3856962A (en) * 1973-07-10 1974-12-24 R Alphin Anti-inflammatory agents
US3895021A (en) * 1973-09-04 1975-07-15 Smithkline Corp N-heterocyclic pulvinic acid amides
AU607735B2 (en) * 1987-05-07 1991-03-14 A.H. Robins Company, Incorporated Novel cyclic carbamate derivatives
US5086055A (en) * 1990-12-24 1992-02-04 A. H. Robins Company, Incorporated Series of 5-[-(4-aryl-1-piperazinyl)alkyl]-2-oxazolidinone derivatives useful in the treatment of allergic conditions
US5162322A (en) * 1991-03-06 1992-11-10 A. H. Robbins Company, Incorporated Method of treating anxiety with 5-[(4-aryl or heteroaryl-1-piperazinyl]alkyl)-2-oxazolidinones
ES2111326T3 (es) * 1993-09-15 1998-03-01 Merck Sharp & Dohme Derivados de imidazolona y oxazolona como antagonistas de dopamina.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2537854A (en) * 1949-07-08 1951-01-09 Hoffmann La Roche Tetrahydropyridines and method of manufacture
US3085093A (en) * 1961-09-25 1963-04-09 Warner Lambert Pharmaceutical 1, 6-bis(2, 2, 6, 6-tetramethylpiperidino)-2, 4-hexadiyne
DE1210874B (de) * 1961-12-14 1966-02-17 Degussa Verfahren zur Herstellung von Diarylaminoderivaten von Arylaminoalkanen

Also Published As

Publication number Publication date
DE1695638A1 (de) 1972-03-02
DK127066B (da) 1973-09-17
BE699845A (fr) 1967-11-16
US3513236A (en) 1970-05-19
US3455941A (en) 1969-07-15
NL6708113A (fr) 1967-12-14
NL130094C (fr) 1900-01-01
CH555845A (de) 1974-11-15
SE325576B (fr) 1970-07-06
IL28125A (en) 1972-07-26
ES341733A1 (es) 1968-07-01
GB1167392A (en) 1969-10-15

Similar Documents

Publication Publication Date Title
AT281852B (fr)
AU5917865A (fr)
AU428063B2 (fr)
AU1141566A (fr)
AU414526B2 (fr)
AU421822B2 (fr)
AU415165B1 (fr)
AU417216B2 (fr)
AU612166A (fr)
AU6703465A (fr)
AU6597365A (fr)
AU218666A (fr)
AU1111066A (fr)
AU5895065A (fr)
BE529218A (fr)
SE325576B (fr)
BE686089A (fr)
BE618801A (fr)
AU415780B2 (fr)
AU92366A (fr)
BE675139A (fr)
BE675626A (fr)
AU855865A (fr)
BE690518A (fr)
BE674713A (fr)